U.S. stock futures are set for a stronger opening on Tuesday, following a decline in crude oil prices that has eased concerns over energy costs. This shift comes as investors prepare for key economic data and earnings reports later in the week, including inflation figures and Nv…
Cerebras Systems' stock has seen a significant decline of 40% since May due to disappointing earnings, yet analysts maintain a positive outlook with a consensus target suggesting…
Nvidia is experiencing its longest losing streak since 2022, with a seven-day decline as it approaches a critical earnings report. Wall Street anticipates $92 billion in revenue a…
Gorilla Technology's stock fell 11% despite reporting nearly double the revenue and raising its 2027 sales forecast significantly above Wall Street expectations. The decline contr…
Advanced Micro Devices (NASDAQ:AMD) shares increased by 2.5% in pre-market trading following an upgrade from Raymond James, which raised its price target from $565 to $641. The fi…
Moderna's shares rose by 2.9% in pre-market trading as they rebounded from a recent decline. This follows a significant rally triggered by positive Phase 3 trial results for its p…
QDM International Inc. has submitted a public offering of common shares as it aims to transition its stock from the OTCQB Venture Market to the Nasdaq Stock Market. The company ha…
Nvidia is set to report its fiscal Q2 2027 earnings on August 26, with options markets indicating a potential 5.4% move in its shares, translating to a $280 billion market value s…
The Indian stock market faced a downturn as geopolitical tensions and concerns over oil prices weighed on investor sentiment. The BSE Sensex and NSE Nifty50 both closed lower, ref…
Datavault AI is facing a critical deadline with Nasdaq as its stock price remains significantly below the required minimum bid price. With the deadline set for August 24, the comp…
Pfizer's stock is receiving a BUY rating from analysts, with a price target of $32.36, indicating a potential upside of 15%. The company has shown strong revenue performance and p…
Zymeworks (NASDAQ:ZYME) shares increased nearly 4% in pre-market trading as investors prepared for a crucial FDA decision regarding zanidatamab, expected on August 25, 2026. The F…
JPMorgan has raised its recommendation for the MSCI Türkiye equity index from neutral to overweight, indicating that the investment fund crisis has subsided and that interest rate…
Tarek Mansour, co-founder and CEO of Kalshi, argues that prediction markets are distinct from traditional gambling platforms like sportsbooks. As Kalshi faces regulatory scrutiny,…
Vice President JD Vance stated that both he and President Trump are still unclear about whether Alice Huang, linked to former Nvidia CEO Jensen Huang, was a Chinese spy. Despite r…
A new beauty industry standard demands that entrepreneurs undertake costly website upgrades, risking financial ruin, while simultaneously navigating impossible beauty regulations…
In a recent speech, Secretary of State Marco Rubio acknowledged the economic hardships facing many Americans while criticizing the use of international law to limit U.S. actions.…
In a stunning display of autonomy, Nvidia's board has reportedly opened an independent investigation into CEO Jensen Huang, all while assuring us that the White House had zero inf…